Scarica l'app Stockscreener
77.80
0.55%
-0.43
Dopo l'orario di chiusura:
77.99
0.19
+0.24%
Panoramica
Notizia
Cronologia dei prezzi
Catena di opzioni
Financials
Forum
Previsione
Storia dei dividendi
Precedente Chiudi:
$78.23
Aprire:
$77.355
Volume 24 ore:
2.57M
Relative Volume:
0.71
Capitalizzazione di mercato:
$32.15B
Reddito:
$9.51B
Utile/perdita netta:
$2.64B
Rapporto P/E:
12.89
EPS:
6.0361
Flusso di cassa netto:
$2.14B
1 W Prestazione:
-2.29%
1M Prestazione:
+8.92%
6M Prestazione:
-33.30%
1 anno Prestazione:
-46.50%
Intervallo 1D:
$77.03
$78.56
Intervallo di 1 settimana:
$77.03
$82.29
Portata 52W:
$68.77
$147.46
Zoetis Inc Stock (ZTS) Company Profile
Nome
Zoetis Inc
Settore
Telefono
973-822-7000
Indirizzo
10 SYLVAN WAY, PARSIPPANY, NJ
Compare ZTS vs TAK, TEVA, HLN, UTHR
| Azioni | Prezzo | Cap. di mercato | Reddito | Reddito netto | Flusso di cassa | EPS |
|---|---|---|---|---|---|---|
ZTS
Zoetis Inc
|
77.80 | 32.15B | 9.51B | 2.64B | 2.14B | 6.0361 |
TAK
Takeda Pharmaceutical Co Adr
|
20.15 | 64.37B | 29.91B | 1.30B | 3.49B | 0.4056 |
TEVA
Teva Pharmaceutical Industries Ltd Adr
|
39.97 | 46.62B | 17.53B | 1.58B | 444.18M | 1.3457 |
HLN
Haleon Plc Adr
|
10.00 | 43.98B | 14.54B | 2.22B | 2.58B | 0.4871 |
UTHR
United Therapeutics Corp
|
586.48 | 25.15B | 3.17B | 1.29B | 1.01B | 27.09 |
Zoetis Inc Stock (ZTS) Upgrades & Downgrades
| Data | Azione | Analista | Modifica della valutazione |
|---|---|---|---|
| 2026-10-20 | Downgrade | Jefferies | Buy → Hold |
| 2026-10-16 | Iniziato | Goldman | Neutral |
| 2026-08-06 | Downgrade | William Blair | Outperform → Mkt Perform |
| 2026-05-27 | Downgrade | Argus | Buy → Hold |
| 2026-04-15 | Iniziato | Citigroup | Buy |
| 2026-01-22 | Downgrade | Piper Sandler | Overweight → Neutral |
| 2025-12-15 | Downgrade | BofA Securities | Buy → Neutral |
| 2025-12-09 | Iniziato | Barclays | Equal Weight |
| 2025-11-21 | Iniziato | KeyBanc Capital Markets | Sector Weight |
| 2025-07-17 | Downgrade | Leerink Partners | Outperform → Market Perform |
| 2025-06-18 | Downgrade | Stifel | Buy → Hold |
| 2024-12-02 | Iniziato | Leerink Partners | Outperform |
| 2024-07-25 | Iniziato | BTIG Research | Buy |
| 2024-01-12 | Reiterato | Stifel | Buy |
| 2023-12-19 | Ripresa | Jefferies | Buy |
| 2023-12-07 | Iniziato | Exane BNP Paribas | Outperform |
| 2023-09-06 | Iniziato | HSBC Securities | Buy |
| 2022-07-12 | Iniziato | Piper Sandler | Overweight |
| 2021-11-18 | Iniziato | Morgan Stanley | Overweight |
| 2021-08-05 | Ripresa | Credit Suisse | Outperform |
| 2021-07-16 | Downgrade | Raymond James | Outperform → Mkt Perform |
| 2021-03-08 | Aggiornamento | BofA Securities | Neutral → Buy |
| 2021-03-08 | Aggiornamento | Raymond James | Mkt Perform → Outperform |
| 2020-09-21 | Iniziato | Atlantic Equities | Overweight |
| 2020-08-14 | Aggiornamento | Edward Jones | Hold → Buy |
| 2020-08-12 | Downgrade | Gabelli & Co | Buy → Hold |
| 2020-05-27 | Iniziato | Jefferies | Buy |
| 2020-01-10 | Iniziato | Raymond James | Mkt Perform |
| 2019-09-09 | Iniziato | Goldman | Buy |
| 2019-07-01 | Downgrade | BofA/Merrill | Buy → Neutral |
| 2019-06-11 | Iniziato | Barclays | Overweight |
| 2019-05-23 | Iniziato | Guggenheim | Buy |
| 2019-05-03 | Downgrade | Gabelli & Co | Buy → Hold |
| 2019-03-20 | Iniziato | SunTrust | Hold |
| 2019-03-04 | Aggiornamento | Stifel | Hold → Buy |
| 2019-01-23 | Iniziato | UBS | Neutral |
| 2018-10-15 | Aggiornamento | JP Morgan | Neutral → Overweight |
| 2018-08-22 | Downgrade | Stifel | Buy → Hold |
| 2018-08-03 | Reiterato | Stifel | Buy |
| 2018-04-19 | Reiterato | Citigroup | Buy |
| 2018-03-19 | Downgrade | Morgan Stanley | Overweight → Equal-Weight |
| 2018-02-16 | Reiterato | Stifel | Buy |
| 2018-01-04 | Aggiornamento | Citigroup | Neutral → Buy |
Mostra tutto
Zoetis Inc Borsa (ZTS) Ultime notizie
Are AT&T and Zoetis Unjustly Punished as Rising Rates Cool Dividend Stock Appeal? - NAI500
Smead Value Fund's Top Q3 2026 Move: Zoetis Inc at a 2.45% Portfolio Impact - Yahoo Finance
Zoetis Inc. (ZTS) - Milk Road
Zoetis Inc. stock underperforms Tuesday when compared to competitors - MarketWatch
3 Absurdly Cheap Dividend Stocks to Buy for Under $100 Right Now - The Motley Fool
Zoetis' Q3 2026 Earnings: What to Expect - Barchart.com
Zoetis Inc. (ZTS) options chain - Yahoo Finance Australia
US98978VAY9 Bond Profile: Coupon and Redemption - TradingView
Zoetis (ZTS) Registers a Bigger Fall Than the Market: Important Facts to Note - Zacks Investment Research
Zoetis (ZTS) Registers a Bigger Fall Than the Market: Important Facts to Note - Yahoo Finance
Zoetis Inc. stock outperforms competitors despite losses on the day - MarketWatch
Zoetis Inc. Estimates – NYSE:ZTS - TradingView
Zoetis Inc. stock outperforms competitors on strong trading day - MarketWatch
Zoetis Lobbying Drops as Farm Bill and Pet Tax Proposal Advance - Legis1
How Unusual Is Zoetis's Latest Sales Growth? - Yahoo Finance
ZTS vs. ICCC: Which Animal Health Stock Is the Better Investment Bet? - Zacks Investment Research
Europe Companion Animal Diagnostics Market Size and Forecast, 20212031 | AI-Enabled Testing and Preventive Pet Care Fuel 9.5% CAGR and a US$2.27 Billion Opportunity - GlobeNewswire Inc.
Zoetis (ZTS) Gains FDA Approval for Convenia RTU for Dogs, Enhan - GuruFocus
Zoetis: Weakening Fundamentals Overshadow The Discount (NYSE:ZTS) - Seeking Alpha
Zoetis Receives FDA Approval for Convenia® RTU for Dogs (cefovecin injectable suspension), Helping More Medium and Large Dogs Access Single-Injection Treatment - Yahoo Finance
Jefferies downgrades Zoetis stock rating on pricing headwinds - Investing.com
Form 4 Zoetis Inc: Julie Fuller (Executive Vice President) For: 30 September - Investing.com Nigeria
Zoetis Inc. stock outperforms competitors on strong trading day - MarketWatch
Zoetis’ Valuation Has Fallen Sharply, but Has the Market Overreacted? - Yahoo Finance
Fund Update: 347,786 ZOETIS (ZTS) shares added to Smead Capital Management, Inc. portfolio - Quiver Quantitative
Zoetis Inc. (ZTS) Options Chain - Yahoo Finance
Zoetis Inc (ZTS) Stock Up 4.2% and Still Undervalued -- GF Score: 71/100 - GuruFocus
Zoetis Inc. stock outperforms competitors on strong trading day - MarketWatch
Zoetis (ZTS) Hit by Guidance Cuts, Met with Market Shrug - Yahoo Finance
Zoetis Inc. stock underperforms Wednesday when compared to competitors despite daily gains - MarketWatch
Form 4 Zoetis Inc: Roxanne Lagano (Executive Vice President) For: 9 October - Investing.com Nigeria
Form 4 Zoetis Inc: Rimma Driscoll (Executive Vice President) For: 9 October - Investing.com Nigeria
An EVP acquires 321.4945 cash-settled stock-linked units at Zoetis (ZTS). - Stock Titan
Zoetis Inc. (ZTS) Stock forecasts - Yahoo Finance Singapore
Zoetis Inc. stock outperforms competitors despite losses on the day - MarketWatch
Zoetis Appoints Iris Knobloch to Board of Directors, Expanding Board to 13 Members - citybiz
Branded Pharmaceuticals Stocks Q2 In Review: Zoetis (NYSE:ZTS) Vs Peers - Yahoo Finance
Zoetis appoints Iris Knobloch to board of directors - Investing.com
Zoetis Appoints Iris Knobloch to its Board of Directors - Business Wire
Zoetis Inc. (ZTS) Stock Forecasts - Yahoo Finance
Zoetis Inc. stock outperforms competitors on strong trading day - MarketWatch
Zoetis: Reducing Our Valuation to Reflect Greater Competitive Pressure, but Moat Remains Intact - Morningstar
Zoetis Inc. (ZTS) Stock Forecasts - Yahoo! Finance Canada
Zoetis Inc. (ZTS) options chain – Yahoo Finance - Yahoo Finance Singapore
Zoetis (ZTS) Stock May Trade At A Discount As Q2 Pressure Persists - Yahoo Finance
Zoetis (ZTS) Outpaces Stock Market Gains: What You Should Know - Zacks Investment Research
Zoetis (ZTS) Outpaces Stock Market Gains: What You Should Know - Yahoo Finance
Zoetis Inc. stock outperforms competitors on strong trading day - MarketWatch
Zoetis Inc. (ZOTS.VI) stock price, news, quote and history - Yahoo Finance UK
Zoetis Inc. stock outperforms competitors on strong trading day - MarketWatch
Zoetis Inc Azioni (ZTS) Dati Finanziari
Reddito
Reddito netto
Flusso di cassa
EPS
Zoetis Inc Azioni (ZTS) insider trading
| Commercio interno | Relazione | Data | Transazione | Costo | #Azioni | Valore ($) | #Azioni Totale |
|---|---|---|---|---|---|---|---|
| Bisaro Paul | Director |
May 13 '26 |
Buy |
75.88 |
2,000 |
151,750 |
27,862 |
| MCCALLISTER MICHAEL B | Director |
May 11 '26 |
Buy |
77.76 |
3,000 |
233,273 |
24,524 |
| PECK KRISTIN C | Chief Executive Officer |
Feb 17 '26 |
Option Exercise |
41.83 |
20,000 |
836,600 |
121,337 |
| PECK KRISTIN C | Chief Executive Officer |
Feb 17 '26 |
Sale |
127.05 |
20,000 |
2,540,964 |
101,337 |
| Polzer Robert J | Officer |
Feb 17 '26 |
Proposed Sale |
127.34 |
2,346 |
298,742 |
0 |
| PECK KRISTIN C | Officer |
Feb 17 '26 |
Proposed Sale |
127.05 |
20,000 |
2,540,964 |
0 |
| Polzer Robert J | Officer |
Feb 13 '26 |
Proposed Sale |
129.09 |
3,662 |
472,728 |
0 |
0.80%
0.27%
Apri su Yahoo
|
Apri su Google
|
Aperto in Finviz
|
Apri in MarketWatch
|
Aperto a EDGAR
|
Aperto su Reuters
Capitalizzazione:
|
Volume (24 ore):